These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20020824)

  • 1. Developing an asymptomatic mucosal herpes vaccine: the present and the future.
    Dasgupta G; Nesburn AB; Wechsler SL; BenMohamed L
    Future Microbiol; 2010 Jan; 5(1):1-4. PubMed ID: 20020824
    [No Abstract]   [Full Text] [Related]  

  • 2. The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.
    Kuo T; Wang C; Badakhshan T; Chilukuri S; BenMohamed L
    Vaccine; 2014 Nov; 32(50):6733-45. PubMed ID: 25446827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design.
    Truong NR; Smith JB; Sandgren KJ; Cunningham AL
    Front Immunol; 2019; 10():373. PubMed ID: 30894859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown.
    Chentoufi AA; Kritzer E; Yu DM; Nesburn AB; Benmohamed L
    Clin Dev Immunol; 2012; 2012():187585. PubMed ID: 22548113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in vaccine development for herpes simplex virus types I and II.
    Coleman JL; Shukla D
    Hum Vaccin Immunother; 2013 Apr; 9(4):729-35. PubMed ID: 23442925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.
    Nicoli F; Gallerani E; Skarlis C; Sicurella M; Cafaro A; Ensoli B; Caputo A; Marconi PC; Gavioli R
    Vaccine; 2016 Apr; 34(19):2216-24. PubMed ID: 27002499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts in herpes simplex virus vaccine development: notes from the battlefield.
    Dasgupta G; Chentoufi AA; Nesburn AB; Wechsler SL; BenMohamed L
    Expert Rev Vaccines; 2009 Aug; 8(8):1023-35. PubMed ID: 19627185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.
    Gierynska M; Kumaraguru U; Eo SK; Lee S; Krieg A; Rouse BT
    J Virol; 2002 Jul; 76(13):6568-76. PubMed ID: 12050369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of currently unavailable herpes virus vaccines.
    Rajčáni J; Bánáti F; Szenthe K; Szathmary S
    Expert Rev Vaccines; 2018 Mar; 17(3):239-248. PubMed ID: 29313728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4
    Srivastava R; Roy S; Coulon PG; Vahed H; Prakash S; Dhanushkodi N; Kim GJ; Fouladi MA; Campo J; Teng AA; Liang X; Schaefer H; BenMohamed L
    J Virol; 2019 May; 93(9):. PubMed ID: 30787156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel High-Intensity Focused Ultrasound-Treated Herpes Simplex Virus 2 Vaccine Induces Long-Term Protective Immunity against Lethal Challenge in Mice.
    Xiao J; Zhou X; Luo Y; Wang S; Yang Z; Yi Y; Xiong H
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy.
    McGowin CL; Pyles RB
    Future Microbiol; 2010 Jan; 5(1):15-22. PubMed ID: 20020827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice.
    Wang X; Xie G; Liao J; Yin D; Guan W; Pan M; Li J; Li Y
    Virol J; 2011 May; 8():232. PubMed ID: 21575169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice.
    El-Ghorr AA; Williams RM; Heap C; Norval M
    FEMS Immunol Med Microbiol; 2000 Dec; 29(4):255-61. PubMed ID: 11118905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of vaccine research and development of vaccines for herpes simplex virus.
    Johnston C; Gottlieb SL; Wald A
    Vaccine; 2016 Jun; 34(26):2948-2952. PubMed ID: 26973067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses.
    Iyer AV; Pahar B; Chouljenko VN; Walker JD; Stanfield B; Kousoulas KG
    Virol J; 2013 Oct; 10():317. PubMed ID: 24165088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2.
    Burn C; Ramsey N; Garforth SJ; Almo S; Jacobs WR; Herold BC
    J Infect Dis; 2018 Feb; 217(5):754-758. PubMed ID: 29216362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.
    Sato A; Suwanto A; Okabe M; Sato S; Nochi T; Imai T; Koyanagi N; Kunisawa J; Kawaguchi Y; Kiyono H
    J Virol; 2014 Dec; 88(23):13699-708. PubMed ID: 25231301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated Phenotype and Immunogenic Characteristics of a Mutated Herpes Simplex Virus 1 Strain in the Rhesus Macaque.
    Fan S; Xu X; Liao Y; Wang Y; Wang J; Feng M; Wang L; Zhang Y; He Z; Yang F; Fraser NW; Li Q
    Viruses; 2018 May; 10(5):. PubMed ID: 29724057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpesvirus vaccines: challenges and future prospects.
    Smith C; Khanna R
    Hum Vaccin; 2010 Dec; 6(12):1062-7. PubMed ID: 21150281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.